Private equity investor Cinven is acquiring MBCC Group’s admixture business from Swiss construction chemicals major Sika on the rebound. Earlier, the British Competition...
Mergers & acquisitions activity in the chemical distribution industry was high in 2021, but current macro-economic conditions may have a dampening effect on the number of...
Private equity investor Cinven is poised to acquire Bayer’s Environmental Science Professional (ESP) unit, Bloomberg has reported. The news agency’s sources said the...
Lonza has signed a definitive agreement to divest its Specialty Ingredients business to Bain Capital and Cinven for an enterprise value of CHF 4.2 billion.
31.10.2014
- Buoyed by a strong performance in its Healthcare and CropScience businesses in the third quarter, Bayer has raised its forecast for full year 2014. CEO Marijn Dekkers said he...
24.10.2014
- Private equity companies Advent, Carlyle, Cinven, CVC and KKR are reported to be interested in teaming up with each other or sovereign wealth funds to bid for Bayer MaterialScience...
24.02.2014
- Private equity firm Cinven, based in London, has agreed to acquire U.S. pharmaceutical contract research organization Medpace from buyout firm CCMP Capital Advisors for a little...
15.10.2012
- Private equity group Cinven is buying family-owned niche pharmaceuticals business Amdipharm for 367 million pounds ($590 million), it said on Monday, as part of a plan to create a...
